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AbsTrACT
background Experiencing illness in low-income and 
middle-income countries (LMICs) can incur very high 
out-of-pocket (OOP) payments for healthcare and, 
while the existing literature typically focuses on levels 
of expenditure, it rarely examines what happens when 
households do not have the necessary money. Some 
will adopt one or more ‘coping strategies’, such as 
borrowing money, perhaps at exorbitant interest rates, or 
selling assets, some necessary for their future income, 
with detrimental long-term effects. This is particularly 
relevant for chronic illnesses that require consistent, 
long-term OOP payments. We systematically review 
the literature on strategies for financing OOP costs of 
chronic illnesses in LMICs, their correlates and their 
impacts on households.
Methods We searched MEDLINE, EconLit, EMBASE, Global 
Health and Scopus on 22 October 2018 for literature 
published on or after 1 January 2000. We included 
qualitative or quantitative studies describing at least one 
coping strategy for chronic illness OOP payments in a LMIC 
context. Our narrative review follows Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses reporting 
guidelines.
results Forty-seven papers were included. Studies 
identified coping strategies for chronic illness costs that 
are not traditionally addressed in financial risk protection 
research (eg, taking children out of school, sending them to 
work, reducing expenditure on food or education, quitting 
work to give care). Twenty studies reported socioeconomic 
or other correlates of coping strategies, with poorer 
households and those with more advanced disease more 
vulnerable to detrimental strategies. Only six studies (three 
cross-sectional and three qualitative) included evidence 
of impacts of coping strategies on households, including 
increased labour to repay debts and discontinuing 
treatment.
Conclusions Monitoring of financial risk protection 
provides an incomplete picture if it fails to capture the 
effect of coping strategies. This will require qualitative 
and longitudinal research to understand the long-term 
effects, especially those associated with chronic illness 
in LMICs.
bACkground
Financial risk protection has long been recog-
nised as a core objective of universal health 
coverage (UHC), now included explicitly 
in the United Nations Sustainable Devel-
opment Goal (SDG) 3 on health and well-
being. Thus, the relevant target is to ‘Achieve 
universal health coverage, including finan-
cial risk protection, access to quality essential 
key questions
What is already known?
 ► Extensive research shows that chronic illnesses can 
increase household expenditure, but the range of 
strategies households use to cope with chronic out-
of-pocket healthcare payments, the determinants 
of these strategies and their long-term impact on 
households, are less well understood.
What are the new findings?
 ► Households with chronic illnesses employ a range of 
strategies not traditionally captured in financial pro-
tection research, for example, taking children out of 
school or stopping treatment, and there is also het-
erogeneity within single types of coping strategies 
(eg, sale of productive vs non-productive assets).
 ► Very few studies have considered determinants 
of detrimental coping strategies, while qualitative 
work suggests coping strategies can lead to long-
term indebtedness, exacerbated illness, stigma and 
strained social relationships.
What do the new findings imply?
 ► Efforts to monitor financial protection must consider 
a wider range of strategies used by households with 
chronic illness to cope with healthcare costs, as a 
failure to account for their impacts will underesti-
mate the gap in financial risk protection.
 ► More qualitative and longitudinal research is need-
ed to inform ways to support vulnerable groups and 
more comprehensively monitor financial risk pro-
tection, particularly in LMICs underrepresented in 
health systems research.
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box 1 sample search strategy (Medline)
MEdLInE
1. exp Fees, Medical/
2. exp Hospital Costs/
3. (“health care” or “healthcare” or “medical cost*” or “medical fee*” 
or “hospital cost*” or “hospital fee*” or “health expenditure*” or 
“catastrophic adj2 expenditure*” or “catastrophic adj2 spending” or 
“out-of-pocket” or “health shock*”).ab. or (“health care” or “health-
care” or “medical cost*” or “medical fee*” or “hospital cost*” or 
“hospital fee*” or “health expenditure*” or “catastrophic adj2 ex-
penditure*” or “catastrophic adj2 spending” or “out-of-pocket” or 
“health shock*”).ti.
4. (coping or cope or “distress finance*” or “hardship finance*” or 
“consumption smoothing” or “income smoothing” or “consumption 
insurance”).ab. or (coping or cope or “distress finance*” or “hard-
ship finance*” or “consumption smoothing” or “income smoothing” 
or “consumption insurance”).ti.
5. (household* or family or families).ab. or (household* or family or 
families).ti.
6. 1 or 2 or 3
7. 4 and 5 and 6
healthcare services….for all’.1 Yet, accurately measuring 
financial risk protection is a challenge. The 2017 WHO 
and World Bank (WB) Global Monitoring Report on 
UHC (entitled ‘Tracking Universal Health Coverage’) 
proposes measures such as ‘catastrophic’ health expendi-
tures (expenditures that are higher than a given propor-
tion of household resources) and ‘impoverishing’ health 
expenditures (expenditures that push households below 
the poverty line), with the goal of protecting 100% of the 
population from both of these.2 However these measures 
may underestimate the full economic impact of health-
care expenditure on many households as they fail to take 
into account the strategies employed to cope with these 
costs.3 4 Few people in many low-income and middle-in-
come countries (LMICs) are able to pay large sums from 
current income or to draw on savings5 6 to pay healthcare 
bills, and so must resort to alternative strategies, including 
borrowing money or selling assets.4 6 Such responses are 
variously termed ‘coping strategies’ or ‘distress’7–9 or 
‘hardship financing’.6 Although they allow households 
to pay for care for short periods, they conceal potential 
longer-term economic consequences4 (eg, those arising 
from repayment of high interest loans, or lost returns 
after sale of productive assets), which are not captured 
by conventional measures of financial protection. These 
longer-term consequences, both economic and non-eco-
nomic, may be severe, including inability to invest in 
education,10 reducing food consumption, compromising 
on timely medical care or returning to work before 
having fully recovered11 in order to meet financial obli-
gations. All of these risks push households further into 
poverty and trap them there.4 12 Flores et al estimated that 
the poverty head count in India would increase by 0.6 
percentage points (a large absolute increase given India’s 
population) if the use of savings, borrowing money or 
selling assets to finance healthcare was accounted for.4 
However, the range of strategies employed by households 
likely extends beyond those commonly cited, with each 
strategy having a different impact.
The consideration of financial risk protection is 
particularly relevant given increased recognition of the 
economic burden of chronic illnesses, in particular 
non-communicable diseases (NCDs, eg, cardiovascular 
disease (CVD)),7 and chronic infectious diseases (eg, 
HIV13) on patient households. The advent of modern, 
life-sustaining treatment means that affected house-
holds must make regular, often lifelong, out-of-pocket 
(OOP) payments for follow-up care and drug treatment. 
This contrasts with the one-off or time-limited payments 
needed for acute conditions. The challenges are exacer-
bated by how chronic illnesses often diminish ability to 
work, with consequent loss of income.14 15 While there 
is now extensive research on how chronic illnesses can 
increase household expenditure, the range of strate-
gies households use to cope with chronic OOP health-
care payments, and their long-term impact, are less well 
understood. Given the increasing prevalence of chronic 
NCDs in LMICs, a failure to account for these strategies 
and their impacts will underestimate the gap in financial 
risk protection,4 and prevent accurate evaluation of the 
effects of policy responses designed to improve financial 
risk protection.16
We set out to review systematically the literature on 
strategies used by households to cope with healthcare 
costs for chronic illnesses. Our objective is to review 
current knowledge and identify evidence gaps regarding 
the range of strategies employed for financing health-
care costs of chronic illnesses, their determinants, and 
the potential long-term social, financial and health 
impacts.
METHods
This review has been registered on the PROSPERO 
international prospective register of systematic 
reviews, with the record number CRD42018113014. 
We searched key health sciences, health economics 
and public health databases—MEDLINE, EconLit, 
EMBASE and Global Health, and one multidiscipli-
nary database, Scopus, on 22 October 2018. A sample 
search strategy (from MEDLINE search) is included in 
box 1. A table outlining our inclusion and exclusion 
criteria is included as online supplementary file 1. We 
searched for literature published in English on or after 
1 January 2000. Initial screening on title and abstract 
was carried out by AM and CM and sought to identify 
potentially relevant qualitative or quantitative studies 
describing at least one coping strategy for dealing with 
chronic illness in a LMIC context. (Countries were 
included if they were defined as LMIC by WB country 
classifications17 at any point from 1 January 2000 
to the day of the search). Papers from high-income 
countries or those focusing exclusively on general 
healthcare or acute illness were excluded. Papers that 
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Figure 1 The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart.
specified a focus on both acute and chronic illnesses 
were included; however, only those data reporting on 
coping with chronic illnesses were extracted. Papers 
that did not specify the type of illness (eg, general 
healthcare) were excluded. Disagreements about 
inclusion of sources were discussed by AM and CM 
and were included after consensus was reached. Data 
from full-text sources were extracted by AM using the 
following headings: first author, year, country, disease 
focus, study type, any coping strategies identified, 
factors affecting coping strategy choice, socio-eco-
nomic status (SES) differences in coping strategy 
choice and impacts of coping strategy. We anticipated 
that studies would not be sufficiently homogenous to 
either justify or permit carrying out a meta-analysis. We 
used a narrative synthesis approach to review evidence 
from included studies and the implications of different 
study approaches for findings. Our review report 
follows the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA).18
Patient and public involvement
Patients were not involved in the design or conduct of 
this systematic review.
rEsuLTs
study context and methods
The PRISMA flow chart is included in figure 1. Forty-seven 
papers met our inclusion criteria and were included in 
the narrative synthesis (table 1 and online supplementary 
file 2).
Characteristics of the included studies, including WB 
region, disease type and type of study are summarised in 
table 1. Almost all included studies relied on cross-sec-
tional surveys (n=32). The remainder used either 
prospective longitudinal studies (n=4), qualitative 
methods (n=8) or mixed methods (n=3).
Coping strategies identified
While most studies used the broad categories of strate-
gies for coping with healthcare costs commonly covered 
in international household surveys (eg, using income/
savings, borrowing money or selling assets) some drilled 
down to distinguish between types of borrowing and 
asset sales.19–28 For example, some studies examined who 
households borrowed from, noting that those forced to 
borrow from moneylenders faced higher interest rates 
than those borrowing from family or friends.25 26 28 The 
diversity of strategies was revealed in a study of households 
containing women with breast cancer. Although almost 
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Table 1 Number of included studies by geographical 
region, disease category and type of study
Number 
of 
studies*
Per cent of 
all studies 
included 
(%)
World Bank region
  Sub-Saharan Africa 20 43
  East Asia and Pacific 11 23
  South Asia 12 26
  Europe and Central Asia 4 9
  Latin America and Caribbean 3 6
  Middle-East and North Africa 1 2
Disease category
  HIV/AIDS or TB 26 55
  CVD and hypertension 8 17
  Diabetes 3 6
  Cancer 3 6
  Physical disability 2 4
  Mental disorder 1 2
  Renal disease 1 2
  Chronic obstructive pulmonary 
disease
1 2
  Sickle cell disease 1 2
  Combined chronic diseases 4 9
Study type
  Cross-sectional 32 68
  Longitudinal 4 9
  Qualitative 8 17
  Mixed-methods 3 6
*Numbers for region and disease category add to more than 47 as 
some studies covered more than one region or disease category.
CVD, cardiovascular disease; TB, Tuberculosis.
85% and 75%, respectively, were able to borrow at low 
interest rates or obtain support from families and friends, 
most also had to pawn personal items such as jewellery, 
borrow money at high interest rates or sell financial assets 
(shares, gold, etc) or economically productive assets, 
such as cattle. Most used a combination of strategies.25 
A study of households with non-specific chronic condi-
tions, also in India, found evidence that households may 
mortgage assets to pay for healthcare costs.29
Several studies provided evidence of other strategies 
to cope with healthcare costs that may have detrimental 
long-term impacts. These included: taking children 
out of school or sending them to work,13 21 25 27 30–32 
reducing expenditure on food, education or social activ-
ities,13 28 32–37 institutionalising a child or adult patient,13 
taking on extra work,13 32 38 39 quitting work to take on 
the role of caregiver,13 40 replacing labour (eg, a wife 
taking on ill husband’s work),41 taking a donation 
from a healthcare provider,41 or moving to cheaper or 
free accommodation.21 Coping strategies with more 
immediate potential impacts on health were also iden-
tified.21 28 34 42 For example, patients with HIV/AIDS in 
Zimbabwe reported coping with the costs of their treat-
ment by: seeking alternative treatment, seeking cheaper 
treatment, delaying treatment or stopping treatment 
altogether.34 Thus, such responses may, in the long term, 
be detrimental by increasing the risk of future costs, 
creating a downward spiral.
determinants of coping strategies
Only 20 of the 47 included provided some evidence of 
the factors correlated with different coping strategies. 
These included demographic factors, with one study of 
households with chronic illness in Russia, which found 
that female-headed households and households with a 
higher number of old people were more likely to receive 
gifts or family transfers to finance healthcare (although 
the study does not clarify a threshold for ‘old’).43 Patient 
exit interviews in South Africa found that patients with 
HIV or TB were more likely to borrow money or sell 
assets to pay for healthcare than were obstetric patients, 
and that borrowing money was more common among 
patients from rural versus urban areas.44 More severe 
disease was associated with an increased likelihood of 
distress financing generally among patients with cancer,25 
and of cattle sale among patients with HIV.45 Those with 
CVD46 or angina7 were more likely to borrow or sell assets 
to pay for healthcare than those without these diseases. 
The extent of a household's social capital was also found 
to influence coping strategy (eg, receiving support 
from a local Non-governmental organisation (NGO) as 
opposed to having to sell assets or compromise treatment 
quality).34
Among those studies that found an association between 
coping strategy and socioeconomic status, poorer house-
holds are more likely to engage in detrimental coping 
strategies such as taking high-interest loans, sale of assets, 
withdrawing children from school and reducing food 
consumption, while wealthier households are more likely 
to rely on insurance, income or savings.8 25 28 29 47 (One 
study found that middle-class households were more 
likely to sell assets than poor or rich households.48) In 
Iranian households containing someone with cancer, 
those who had experienced catastrophic spending were 
more likely to borrow money or sell property.49 Perhaps 
unsurprisingly, patients with HIV/AIDS in Namibia who 
had private insurance were less likely to take grants or 
gifts, sell assets, decrease consumption, or take loans to 
finance healthcare costs.36
Households in Punjab, India containing a woman with 
breast cancer were significantly more likely to report 
reduced expenditure on food, education and social 
events, as well as early entry into the labour market if the 
household was poorer.25 On the other hand, one study of 
households containing patients living with HIV/AIDS in 
Zimbabwe found that those in poorer households more 
often relied on social resources, such as support from 
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other households, community groups or local NGOs, 
perhaps because they had higher social capital.34
Impacts of coping strategies
Only six studies included some evidence of the long-
term impacts of coping strategies on patient households. 
In three different cross-sectional studies, participants 
reported using multiple sources such as asset sale and 
increased labour to repay debts from having borrowed 
money,50 discontinuing treatment due to cost23 and 
depleting their savings to pay for healthcare costs.24 One 
qualitative study of patients with acute coronary syndrome 
included interviews with families about coping strate-
gies at the time of the event and during the subsequent 
6-month period. It found that families who borrowed 
money from moneylenders to finance their healthcare 
were often exploited, with seizure of property deeds or 
other assets used as security when families were unable 
to repay, leading to prolonged, or lifelong, indebtedness. 
Patients' families also faced being stigmatised as 'charity 
cases'.21 In Sri Lanka, another qualitative study found 
that many households containing patients with diabetes 
had to sell income-generating assets, leading to reduced 
future household earnings. The burden was further exac-
erbated when households could no longer afford treat-
ment, leading to complications of diabetes and further 
costs.27 Finally, a qualitative study with patients with 
TB in China found that engaging in strategies such as 
borrowing, selling assets or receiving transfers or dona-
tions resulted in household resources being exhausted, 
compromises made on medications, strained social rela-
tionships, and feelings of stigma and shame.41
dIsCussIon
The United Nations has committed to achieving UHC 
for all, including financial risk protection, with addi-
tional commitments in relation to reducing the burden 
of NCDs.51 Important work has been done to show how 
measures to expand insurance coverage in LMICs, espe-
cially to the poorest families and those with children and 
older adults, can achieve the greatest improvements in 
financial protection.52–54 However, efforts to monitor 
progress towards UHC will be incomplete without recog-
nising the range of types of coping strategies employed 
by households to finance healthcare expenditures, their 
potential detrimental impacts on household health and 
economic security, and those groups in the population 
that are most vulnerable. These include those with 
chronic illness in many LMICs, where households can 
face long-term, and often lifelong, OOP payments for 
healthcare. Our review highlights gaps in research on 
this topic.
First, most widely used surveys, including the World 
Health Survey55 and WHO Study on Global AGEing 
and Health,56 attempt to estimate the prevalence of a 
limited set of coping strategies (current income, savings, 
health insurance, selling items, borrowing from friends 
or family, borrowing from someone else, and ‘other’). 
Those surveys, and similar others, have facilitated 
important multicountry research on the prevalence of 
detrimental coping strategies.6 43 57 However, our review 
has shown that households with chronic illnesses employ 
a range of strategies not traditionally captured in those 
metrics, for example, taking children out of school. 
The positive impact that childhood education can have 
on a household’s long-term economic prospects, and 
the detrimental impact that low education has on the 
economic development of societies, generally, are well 
established.58–60 Completion of primary and secondary 
education for all children is another SDG target,1 and 
the WB’s Human Capital programme aims to invest in 
young people’s education and skill-building as a means 
to reduce poverty and inequality.61 In countries where 
primary and secondary education are not provided freely, 
competing demands for household financial resources, 
such as debt incurred from OOP payments for health-
care, may compromise progress towards these goals.
Coping strategies with a more direct impact on the 
health of the household member suffering chronic 
illness were also identified, and these may have adverse 
longer-term economic repercussions for the households. 
Stopping or delaying treatment, or seeking alternative 
treatment for conditions and diseases like hypertension, 
CVD and diabetes, can increase the risk of acute events 
such as myocardial infarction62 (which are costlier to 
treat and require hospitalisation), or of death. Future 
research on financial risk protection for households with 
chronic illness should include a broader range of poten-
tial coping strategies or allow for open-ended questions 
about coping with healthcare costs.
Second, our review supports the conclusion that there 
is heterogeneity within single types of coping strategies 
used for chronic illness costs. Knowing whether, in the 
case of borrowing, loans were high interest,63 64 whether 
assets sold were productive,65 or whether assets were 
essential to current consumption or surplus to require-
ments,9 are crucial in understanding the potential long-
term impact on families of patients. For example, previous 
research on coping with costs of general healthcare in 
India showed that borrowing is primarily from informal 
moneylenders who lend at high rates of interest,12 which 
may drive poorer households into debt bondage.35 66 
Collecting more detail on commonly reported strategies 
among households with chronic illness should be a 
priority for future research.
Third, our review highlights the need for further 
research on determinants of coping strategies, which can 
help to focus research and policy initiatives on particu-
larly vulnerable populations. The research we reviewed 
provides some insights, although some may seem predict-
able, such as evidence that advanced disease is associ-
ated with an increased likelihood of distress financing 
among patients with cancer in India.25 It may also seem 
predictable that poorer households are more likely to 
engage in potentially detrimental coping strategies, but 
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contradictory evidence that patients with HIV/AIDS in 
poorer communities of Zimbabwe were more likely to 
take advantage of social resources, such as support from 
other households and local NGOs to finance health 
expenditures, shows that it is not inevitable. The poten-
tial for measures to strengthen these networks, or at least 
avoid those that undermine them, should be explored as 
a means to improve protection for households, as well as 
to ensure that new policies, in any sector, do not under-
mine them.
Fourth, and perhaps most important for understanding 
the impact of healthcare costs for chronic illnesses, our 
review uncovered only minimal evidence of the potential 
long-term impacts of coping strategies on households. 
Perhaps the strongest contribution to this evidence was 
made by qualitative research, providing a richness of data 
difficult to achieve with quantitative methods, with details 
of how, for example, the burden of healthcare debt 
can exacerbate the poor health of those with diabetes, 
resulting in increased risk for acute disease phases and 
higher healthcare costs.27 It is likely that many of the 
coping strategies identified such as taking high-interest 
loans or selling productive assets will have a more severe 
impact on poorer households, further exacerbating ineq-
uity in health and economic well-being. It is also possible 
that some strategies are more likely to negatively affect 
women and girls in the household, for example, leaving 
work to take on caregiving duties or withdrawing from 
school. More qualitative work is needed to understand 
these impacts. To complement cross-sectional approaches 
however, whether quantitative or qualitative, longitudinal 
research is required to better understand long-term 
effects of coping strategies, including those on socio-
economic and gender equity. We did not identify any 
longitudinal studies of the long-term impacts of coping 
strategies in our review. Future efforts to collect longitu-
dinal data might include research that spans generations, 
given that several of the coping strategies identified can 
be expected to have important intergenerational conse-
quences, and the emerging body of research on the 
health effects of intergenerational mobility.67 This could 
shed light on the complex and dynamic processes that 
influence how households will be affected by healthcare 
costs.68
Finally, our review uncovered gaps in the diseases and 
geographical regions included in existing research. The 
majority of studies included in our review focused on HIV 
or TB. While these continue to be major contributors to 
disease burden in many LMICs, other chronic NCDs, 
including CVD and cancer are increasingly important 
in these countries. These are not sufficiently addressed 
in the literature to date.15 While the available evidence 
regarding coping strategies for HIV/TB may be infor-
mative for NCDs, it likely does not accurately reflect the 
burden of coping with costs for chronic NCDs given the 
absence of external aid funding for chronic NCDs. There 
is also an increasing prevalence of chronic multimorbidi-
ties in LMICs, for example, HIV and CVD, which impose 
an even greater economic burden.69 The almost complete 
absence, save one study, on coping with the costs of 
mental disorders highlights the failure to recognise the 
increasing health and economic burden of mental disor-
ders globally,70 and the need for more research in this 
area. While our review suggests that there is at least some 
research on strategies for coping with costs of chronic 
illness in every region containing LMICs, there are many 
countries that are not represented at all, or where no 
more than one study has been conducted. More research 
is required from all LMICs to inform nationally relevant 
policy responses.
Limitations
Our review did not explore another limitation of tradi-
tional measures of financial risk protection, that is the 
economic burden faced by households who forego 
care altogether due to costs. Understanding the extent 
to which OOP costs prevent households from seeking 
necessary care is indeed another crucial indicator of 
UHC, and suggestions for how to incorporate that in 
monitoring efforts have been made by others.3 We also 
did not explore how households cope with the psycho-
social burden of healthcare expenditures, such as effects 
of costs on the mental health of patients, caregivers and 
families, which may be exacerbated by coping strate-
gies (for example by stigma associated with borrowing 
money). Approaches for including this burden in more 
comprehensive monitoring of financial risk protection 
should be considered.
We only included English-language papers so we 
may have missed relevant papers published in other 
languages, potentially leading to underrepresentation of 
countries where English is not used.
ConCLusIon
Although the potentially detrimental long-term impacts 
of coping strategies are widely acknowledged,4 6 9 63 
there is relatively little understanding of different types 
of coping strategies for chronic illnesses, their determi-
nants and the long-term impacts on households. Our 
review identifies coping strategies not normally captured 
by international research on financial protection. It also 
suggests some potential determinants of coping strate-
gies for chronic illness costs such as socioeconomic status 
and disease severity, and negative long-term impacts on 
household health and socioeconomic status. However, 
more qualitative and longitudinal research, including 
studies spanning generations, is needed to inform ways 
to support vulnerable groups and more comprehensively 
monitor financial risk protection, particularly in LMICs 
underrepresented in health systems research.71
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